目的探讨米非司酮在人工流产中的临床意义。方法对服药组50例自愿选择人流的患者给予术前1天口服药物,观察宫口扩张情况、人流综合征及流产后出血量。结果服药组在口服药物后术中宫口扩张明显、人流综合征例数减少或症状明显减轻、出血明显减少。结论人流术前口服米非司酮在临床上明显减轻了患者的痛苦,疗效满意。 Objective To investigate the clinical significance of mifepristone in induced abortion. Methods Fifty patients in the medication group who voluntarily chose to take the flow were given oral medication one day before operation to observe the dilatation of the cervix, the flow syndrome and the amount of bleeding after abortion. Results In the medication group, the intrauterine cervix dilated obviously after oral administration. The number of abortion syndromes was reduced or the symptoms were relieved, and the bleeding was obviously reduced. Conclusion Preoperative abortion mifepristone in patients with clinically significantly reduced the pain of patients with satisfactory results.